20MayMay 20, 2026 Exploring New Options in Obesity Treatment Through Clinical Research ND-Negin2026-05-20T22:19:13+00:00Diabetes, high blood pressure and obesity are driving a rise in kidney disease. Learn the risks, new treatments and San Antonio clinical trial options at Quality Research. By ND-NeginClinical TrialsCagriSema, clinical research, GLP-1 medications, metabolic health, Novo obesity study, obesity clinical trial, obesity treatment, semaglutide study, weight loss study Read more...